Jump to Navigation

ZUMA-3

 Titel: A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Subjects with Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-3)

NB Enrollment has been paused as of 24Jul19.


Studiemedicatie:

BEACONprotocol beschikbaar:

Verpleegkundige documenten:

Principal Investigator AMC: Marie Jose Kersten

Studie coordinator: Rob Liu

Aanmelden patienten via trialbureau hematologie (sein 59255, hemat.trial@amc.nl)


Onder beheer van afdeling: 
Geen